RxDoctor Payments DataLook up a doctor →

Andrew Roth, MD

Obstetrics & Gynecology · Lombard, ILNPI 1790787521

Payments from drug & device makers

$15,353in general payments, 2019–2025

Across 568 payments — averaging $27.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • AbbVie$3K
  • Novo Nordisk$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • IBSA Pharma Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$700
  • plus $4K from 43 others

What the payments were for

  • Consulting fees$2,51016%
  • Speaking & faculty fees$3,41522%
  • Food & beverage$9,27560%
  • Education$1531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,353 in reported general payments places this provider in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$187,361
Medicare patients
165
Services billed
3,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated14$4,286
ProgesteroneProgesterone, Micronized11$747
Levothyroxine Sodium57$492
Estradiol26$488
Simvastatin47$482
Oxybutynin Chloride ErOxybutynin Chloride14$455
Pravastatin Sodium15$394
Pantoprazole Sodium22$330
Atorvastatin Calcium34$317
Gabapentin14$271
Rosuvastatin Calcium36$265
Ethambutol Hcl11$255
Metformin Hcl ErMetformin Hcl24$254
Losartan Potassium20$213
Escitalopram Oxalate15$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$3,906$4,28614 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$49257 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,732 obstetrics & gynecology providers in Illinois.

Other obstetrics & gynecology in Lombard

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →